Boehringer Ingelheim and IBM announced an agreement that will enable Boehringer to use IBM’s foundation model technologies to discover novel candidate antibodies for the development of efficient therapeutics. “We are very excited to collaborate with the research team at IBM,…
Roche today announced the launch of Elecsys® HBeAg quant, an immunoassay that is able to determine both the presence and quantity (qualitative and quantitative) of the hepatitis B e antigen (HBeAg) in human serum and plasma. This launch means that,…
Novo Nordisk announced the investment of more than 16 billion Danish kroner (2.1 billion euros) starting in 2023 to expand the existing production site in Chartres, France, for the current and future product portfolio within serious chronic diseases. The investment…
Boehringer Ingelheim today announced the acquisition of privately-held T3 Pharmaceuticals (“T3 Pharma”), a clinical stage Swiss biotech company, for an amount of up to 450 million CHF. T3 Pharma has developed a proprietary therapy platform that uses live bacteria to…
Genentech, a member of the Roche Group today announced a multi-year strategic research collaboration with NVIDIA that couples Genentech’s artificial intelligence (AI) capabilities, extensive biological and molecular datasets, and research expertise with NVIDIA’s world-leading accelerated computing capabilities and AI to…
Sandoz, the global leader in generic and biosimilar medicines, today announces the launch of Hyrimoz® (adalimumab) citrate-free high concentration formulation (HCF; 100 mg/mL) in Europe. The medicine will become available to patients progressively across European markets, starting today. Hyrimoz® HCF,…
Guy’s and St Thomas’ NHS Foundation Trust’ and King’s College London will set up a new HealthTech Research Centre focussing on cardiovascular and respiratory medicine. The centre, based at St Thomas’ Hospital, will work with industry and academic partners as…
Abdi Ibrahim Pharmaceuticals, the leader in the Turkish pharmaceutical industry for 21 years, continues its unwavering commitment to investing in biotechnology. Abdi İbrahim has announced a technology transfer agreement with the Spanish biosimilar developer, which is among the world’s leading…
AstraZeneca today launches Evinova, set to be a leading provider of digital health solutions to better meet the needs of healthcare professionals, regulators and patients. With long-term backing from AstraZeneca and strategic collaborations with Parexel and Fortrea, Evinova offers globally-scaled…
The University of Tsukuba and Astellas Pharma announced that they have signed a letter of confirmation regarding a strategic partnership to accelerate the digitalization of the drug discovery research field, as well as the development of the life science ecosystem…